Navigation Links
Shengtai Pharmaceutical Schedules 2009 First Quarter Financial Results and Conference Call
Date:11/10/2008

WEIFANG, China, Nov. 10 /Xinhua-PRNewswire-FirstCall/ -- Shengtai Pharmaceutical, Inc. (OTC Bulletin Board: SGTI) ("Shengtai" or "the Company"), a leading manufacturer and distributor of high-quality, pharmaceutical grade glucose products in China, today announced that it will issue financial results for the three months ended September 30, 2008 after the close of the stock market on Thursday, November 13, 2008. Management will conduct a conference call on Friday, November 14, 2008 at 9:00 A.M. Eastern Standard Time to discuss these results. A question and answer session will follow management's presentation.

Mr. Qingtai Liu (Chief Executive Officer), Ms. Yiru Melody Shi (CFO), and Ms. Michelle Wang (Investor Relations Manager) will be the primary speakers on the call.

A live webcast of the conference call will be available on the Investor Relations page of Shengtai Pharmaceutical's web site at http://www.shengtaipharmaceutical.com . Please visit the Web site at least 15 minutes early to register for the webcast and download any necessary audio software.

To participate, please call the following numbers ten minutes before the call start time:

Phone Number: +1-877-407-8035 (North America)

Phone Number: +1-201-689-8035 (International)

A replay of the call will be available through Friday, November 21, 2008, at 11:59 P.M. Eastern Standard Time. For the replay, please call:

Phone Number: +1-877-660-6853 (North America)

Phone Number: +1-201-612-7415 (International)

Account Number: 286

Conference ID Number: 302820

About Shengtai Pharmaceutical, Inc.

Shengtai Pharmaceutical, Inc. through its wholly owned subsidiary, Shengtai Holding, Inc. (SHI), a New Jersey corporation, and the Chinese operating company of Weifang Shengtai Pharmaceutical Co., Ltd., is a leading manufacturer and supplier of pharmaceutical grade gluc
'/>"/>

SOURCE Shengtai Pharmaceutical, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. Shengtai Pharmaceutical Completes Factory Improvements Resulting in Operational and Environmental Benefits
2. Shengtai Pharmaceutical Retains Grayling Global As Investor Relations Counsel
3. Shengtai Pharmaceutical, Inc. Appoints New CFO
4. Shengtai Pharmaceutical, Inc. Announces Conference Call to Discuss Second Quarter Results of Fiscal Year 2008
5. Potentia Pharmaceuticals Drug Candidate for Age-Related Macular Degeneration Shows Positive Safety Profile in Phase I Clinical Trial
6. Transdel Pharmaceuticals, Inc. Retains The Investor Relations Group
7. Idenix Pharmaceuticals to Present at Deutsche Banks 2008 Biotech Boston Confab
8. Simcere Pharmaceutical Group to Participate in Morgan Stanley Seventh Annual Asia Pacific Summit 2008
9. Critical Pharmaceuticals Raise GBP650K
10. WellSpring Pharmaceutical Corp. Announces Hire of Wayne Miller as Vice President, Sales & Marketing, Consumer Brands
11. Onyx Pharmaceuticals Licenses Rights to Novel Targeted Oncology Agent From BTG International
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/2/2009)... Executes Master Services Ag...mic QTbtb(sm) Solutions , ...iac Technologies, Inc., a leader in advanced cardi...nalysis, announced that it has executed a master s...pany covering both iCardiac,s Highly Automated QT ...
(Date:7/1/2009)... LONDON, July 1 Johnson & ...director of the Department of Molecular Biology at...ny, whose discoveries have led to novel cancer the...he winner of the 2009 Dr. Paul Janssen Award for B...rld-renowned scientists selected Dr. Ullrich, who ...
(Date:7/1/2009)... Single-dose of investigational sustained follicle...ctions of follitropin beta given over a one week p... Schering-Plough Corp., (...se III ENGAGE clinical trial demonstrating that a ... the class of sustained follicle stimulants, achie...
(Date:7/1/2009)... ROCKVILLE, Maryland, July 1 /PRNewswire-USNewswir...) today announced that it expects to have top-line...52, the first of two pivotal Phase 3 clinical tria...-B(R)) in systemic lupus erythematosus (SLE). ,.../20080416/HGSLOGO ) , , Senior management wi...
Breaking Biology Technology:iCardiac Selected by Top 10 Pharmaceutical Company 2Video: Axel Ullrich Named Winner of 2009 Dr. Paul Janssen Award for Biomedical Research 2Video: Axel Ullrich Named Winner of 2009 Dr. Paul Janssen Award for Biomedical Research 3Video: Axel Ullrich Named Winner of 2009 Dr. Paul Janssen Award for Biomedical Research 4Video: Axel Ullrich Named Winner of 2009 Dr. Paul Janssen Award for Biomedical Research 5Schering-Plough Announces Phase II and III Data for Corifollitropin Alfa 2Schering-Plough Announces Phase II and III Data for Corifollitropin Alfa 3Schering-Plough Announces Phase II and III Data for Corifollitropin Alfa 4Schering-Plough Announces Phase II and III Data for Corifollitropin Alfa 5Schering-Plough Announces Phase II and III Data for Corifollitropin Alfa 6Schering-Plough Announces Phase II and III Data for Corifollitropin Alfa 7Schering-Plough Announces Phase II and III Data for Corifollitropin Alfa 8Schering-Plough Announces Phase II and III Data for Corifollitropin Alfa 9Human Genome Sciences to Host July 20 Conference Call to Discuss Top-Line Phase 3 Results for Benlysta(TM) (Formerly Lymphostat-B(R)) in Systemic Lupus Erythematosus 2
... Editor,s note: This is the fifth in a series of a...chnology or biotechnology sectors. , , Madison,...lectual property is - the domain name, trademarks,... In this column, we will discuss the entity choic...useful at this early stage. , ,In today,s landscap...
... Madison, Wis. - Guess which governor said the ...me the energy capital of the world. , ,B. To lead,...y to power our lives and propel our state,s econom... even more boldly toward energy independence. , ,D... New Energy Economy. , ,E. The policies that helpe...
... Madison, Wis. - Aruna Biomedical , a Georgia-ba..., will relocate to Wisconsin if it can raise suffi...e confirmed. , ,The company, spun out of the Univ... funding commitments from the State of Wisconsin a...-based angel investment network, but it will need ...
... Madison, Wis. - Ed Meachen has an interconnected...one that would be impossible to imagine and execut...iate vice president of learning and information te...the University of Wisconsin-Superior someday sig...em,s flagship university, UW-Madison . , ,And why...
Other Biology Technology:Early Stage: Step 5 - Forming the entity 2Early Stage: Step 5 - Forming the entity 3Early Stage: Step 5 - Forming the entity 4Wisconsin will have plenty of competition in building the energy future 2Wisconsin will have plenty of competition in building the energy future 3Wisconsin will have plenty of competition in building the energy future 4Wisconsin tries to woo another stem cell company 2Wisconsin tries to woo another stem cell company 3CIO Leadership Series: Ed Meachen, University of Wisconsin System 2CIO Leadership Series: Ed Meachen, University of Wisconsin System 3CIO Leadership Series: Ed Meachen, University of Wisconsin System 4CIO Leadership Series: Ed Meachen, University of Wisconsin System 5
(Date:7/2/2009)...searchers from the National Oceanography Centre, S...f oceanographic knowledge to investigate the distr...ab. The results, published this week in the Jour...ing force behind the speciation and radiation of a...of millions of years of Earth,s history. , In d...
(Date:7/2/2009)...ientists are to study a group of proteins that are...uld hold the key to developing new types of antibi...rk and Leeds have been awarded 3.3m from the Biote...(BBSRC) to find out how a family of proteins known...before destroying them. , The team, led by Profe...
(Date:7/1/2009)...ndon, 1 July, 2009 Johnson & Johnson today announ...rtment of Molecular Biology at the Max Planck Inst...s have led to novel cancer therapies including Her...r. Paul Janssen Award for Biomedical Research. An...s selected Dr. Ullrich, who on September 8 will re...
(Date:7/1/2009)...Deleting two genes in mice responsible for repairi...al types of tumors, providing additional evidence ... cancer. That,s the conclusion of a recent study* ...titute of Standards and Technology (NIST), Oregon ...ork University School of Medicine (NYUSM). , Alt...
Breaking Biology News(10 mins):Evolution: Crabs go deep to avoid hot water 2Axel Ullrich named winner of 2009 Dr. Paul Janssen Award for Biomedical Research 2Genetically engineered mice yield clues to 'knocking out' cancer 2Business scientific higher education groups laud President Obamas commitment to science 7914 1Business scientific higher education groups laud President Obamas commitment to science 7914 2Study finds students with Experience Corps tutors make 60 percent more progress in critical reading skills 42053 1Study finds students with Experience Corps tutors make 60 percent more progress in critical reading skills 42053 2Study finds students with Experience Corps tutors make 60 percent more progress in critical reading skills 42053 3Study finds students with Experience Corps tutors make 60 percent more progress in critical reading skills 42053 4Study finds students with Experience Corps tutors make 60 percent more progress in critical reading skills 42053 5Study finds students with Experience Corps tutors make 60 percent more progress in critical reading skills 42053 6Prune juice not necessary 3A New research should make bowel movements easier 42049 1Prune juice not necessary 3A New research should make bowel movements easier 42049 2How tumor cells move 7913 1How tumor cells move 7913 2
...The Quaking gene, first described as a mutation in...ress tumor formation and protect humans from cance... University and the University of Wisconsin has sh...growth by inhibiting production of a protein assoc...associated with severe birth defects and several c...
...Physicians prescribe antibiotics for more than hal...cted prevalence of strep throat, and used nonrecom...received an antibiotic prescription, according to ...itis (inflammation of the throat) accounts for 6 p...ysicians and pediatricians, according to backgroun...
...Researchers at Yale School of Medicine have demons...d been thought to alert the immune system to patho...ion and inflammation. , This has the potential to ...s underlying many skin disorders such as psoriasis...ound throughout the body and are extremely efficie...
...Habitual coffee drinking is not associated with an... an association was found with the consumption of ... November 9 issue of JAMA. , Approximately 50 mill... and the prevalence is increasing, according to ba...is a major risk factor for coronary heart disease,...
Other Biology News:Researchers discover new form of cancer gene regulation 2Researchers discover new form of cancer gene regulation 3Children overprescribed antibiotics for sore throat 2Langerhans cells regulate immune reactions in the skin 2No link found between caffeine intake and development of hypertension in women 2
Liquid. Phycoerythrin conjugate is in PBS, pH 7.4 containing 1% BSA and 0.1% sodium azide.
Supercoiled DNA Ladder is suitable for sizing supercoiled DNA from 2 to 16 kb by agarose gel electrophoresis (1). The bands can be visualized by ethidium bromide staining and may also be detected on
GIBCO RPMI Medium 1640; powder from Invitrogen
Rabbit polyclonal to Parathyroid Hormone Receptor 2 ( Abpromise for all tested applications). Antigen: Synthetic peptide: AFRHCNPNGTWDFMHSLN, corresponding to extracellular amino acids 99-116 of
Biology Products: